在患有恶性黑色素瘤的儿童中,尼沃卢马布相关的IgA脏病
Gizem Yildiz1, Meral Torun Bayram1, Şadiye Mehtat Ünlü2
1Departments of Pediatrics.
Journal of pediatric hematology/oncology
|July 25, 2024
概括
免疫检查点抑制剂可能会导致脏问题. 这份报告详细介绍了第一例患有IgA脏病的儿科病例,这是一种与尼沃卢马布相关的淋巴细胞疾病,没有急性损伤.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 在瘤学瘤学.
背景情况:
- 免疫检查点抑制剂 (ICI) 是一种革命性的癌症疗法,增强T细胞抗瘤活性.
- 然而,ICI与免疫相关的不良事件 (irAEs) 有关,包括毒性,如急性间歇性炎.
- 淋巴细胞疾病,如IgA脏病,最近已被确定为成年人罕见的ICI相关的irAEs,通常伴有急性损伤.
相关概念视频
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
157
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
157


